-
1
-
2Engineered triple inhibitory receptor resistance improves anti-tumor CAR-T cell performance via CD56por Fan Zou, Lijuan Lu, Jun Liu, Baijin Xia, Wanying Zhang, Qifei Hu, Weiwei Liu, Yiwen Zhang, Yingtong Lin, Shuliang Jing, Mei Huang, Bifen Huang, Bingfeng Liu, Hui ZhangEnlace del recurso
Publicado 2019
article